Related Experiment Video

Updated: Dec 30, 2025

Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism
11:04

Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism

Published on: September 1, 2014

11.5K

Assessment of diastolic function: How much more evidence do we need?

Carla Sousa1

  • 1Serviço de Cardiologia, Centro Hospitalar de S. João, EPE, Porto, Portugal.

Revista Portuguesa De Cardiologia
|January 27, 2020
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

16.6K
Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats
08:09

Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats

Published on: December 13, 2019

22.5K

Related Experiment Videos

Last Updated: Dec 30, 2025

Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism
11:04

Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism

Published on: September 1, 2014

11.5K
Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

16.6K
Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats
08:09

Echocardiographic Assessment of Cardiac Anatomy and Function in Adult Rats

Published on: December 13, 2019

22.5K

Related Concept Videos

Assessing Blood pressure using a doppler ultrasound01:19

Assessing Blood pressure using a doppler ultrasound

2.2K
To obtain accurate blood pressure measurements in clinical settings, especially when traditional methods are insufficient, healthcare professionals utilize the Doppler ultrasound technique. This method uses high-frequency sound waves to detect blood flow within the arteries, which is crucial for patients with conditions that complicate circulatory system assessment.
Pre-Procedural Guidelines for Doppler Ultrasound Blood Pressure Assessment:
Preparation of Equipment:
2.2K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

279
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
279

Articles linked to this work by shared authors, journal, and citation graph.

Ramping UBIquitinomics for the design of new sex-specific therapeutic strategies for aortic valve stenosis: study protocol.

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology·2026

Comment on Sun et al. First Experience with Hypothermic Oxygenated Perfusion in Human Uteri: Feasibility and Metabolic Characterization. J. Clin. Med. 2026, 15, 2820.

Journal of clinical medicine·2026

Dissecting sexual dimorphism in aortic valve stenosis by proteomics.

Clinical proteomics·2025

Sodium-Glucose Cotransporter 2 Inhibitor With and Without an Aldosterone Antagonist for Heart Failure With Preserved Ejection Fraction: The SOGALDI-PEF Trial.

Journal of the American College of Cardiology·2025

SGLT2 inhibitor with and without ALDosterone AntagonIst for heart failure with preserved ejection fraction: Design paper.

ESC heart failure·2025

Semaglutide as a GLP-1 Agonist: A Breakthrough in Obesity Treatment.

Pharmaceuticals (Basel, Switzerland)·2025

Acute coronay syndrome in a patient with severe hemophilia A: Dificult decisions.

Revista portuguesa de cardiologia·2021

Optimization of heart failure with reduced ejection fraction prognosis-modifying drugs: A 2021 heart failure expert consensus paper.

Revista portuguesa de cardiologia·2021

Quality of life among adults with repaired tetralogy of fallot: A literature review.

Revista portuguesa de cardiologia·2021

Facemasks during aerobic exercise: Implications for cardiac rehabilitation programs during the Covid-19 pandemic.

Revista portuguesa de cardiologia·2021

Cardiac rehabilitation and improvement of chronotropic incompetence: Is it the exercise or just the beta blockers?

Revista portuguesa de cardiologia·2021

Transapical off-pump mitral valve repair with NeoChord™ implantation: An early single-center Portuguese experience.

Revista portuguesa de cardiologia·2021

Outcomes of Moderate-to-Severe Traumatic Brain Injury in a Low-Resource Setting.

JAMA network open·2026

The effect of treatment-induced resistance in a two-strain tuberculosis model with age structure and spatial diffusion.

Journal of mathematical biology·2026

Lower hepatitis E clearance rates in thoracic organ recipients compared to visceral organ recipients: an effect of stronger immunosuppression?

Infection·2026

Ebola virus disease in the modern era: pathogenesis, therapeutic advances, vaccine strategies, and global health preparedness.

Infection·2026

Cardiovascular Disease (CVD) Risk in Women With Endometriosis: A Comprehensive Meta-Analysis.

Clinical cardiology·2026

Type 2 Diabetes in Heart Failure with Preserved and Mildly-Reduced Ejection Fraction: Insights from the REDUCE-LAP-HF II trial.

ESC heart failure·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us